04:51 PM EDT, 09/09/2025 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said late Tuesday it launched a public offering of common shares.

The company intends to grant underwriters a 30-day option to buy an additional 15% of the shares offered.

Net proceeds, along with cash and cash equivalents, will be used for Avexitide commercial readiness, research and development, and general corporate purposes.

Shares of the company fell 2.9% during after-hours activity.